1 Market Overview
    1.1 Product Overview and Scope of Long-acting Injectable Medications
    1.2 Global Long-acting Injectable Medications Market Size and Forecast
    1.3 China Long-acting Injectable Medications Market Size and Forecast
    1.4 China Percentage in Global Market
        1.4.1 By Revenue, China Long-acting Injectable Medications Share in Global Market, 2020-2031
        1.4.2 Long-acting Injectable Medications Market Size: China VS Global, 2020-2031
    1.5 Long-acting Injectable Medications Market Dynamics
        1.5.1 Long-acting Injectable Medications Market Drivers
        1.5.2 Long-acting Injectable Medications Market Restraints
        1.5.3 Long-acting Injectable Medications Industry Trends
        1.5.4 Long-acting Injectable Medications Industry Policy
2 Competitive Landscape by Company
    2.1 Global Long-acting Injectable Medications Revenue by Company, 2020-2025
    2.2 Global Long-acting Injectable Medications Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Long-acting Injectable Medications Concentration Ratio
    2.4 Global Long-acting Injectable Medications Mergers & Acquisitions, Expansion Plans
    2.5 Global Long-acting Injectable Medications Manufacturers Product Type
    2.6 Global Geographic Distribution of Long-acting Injectable Medications Companies
3 China Competitive Situation by Company
    3.1 China Long-acting Injectable Medications Revenue by Company, 2020-2025
    3.2 China Long-acting Injectable Medications Long-acting Injectable Medications Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    3.3 China Long-acting Injectable Medications Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)
4 Industry Chain Analysis
    4.1 Long-acting Injectable Medications Industry Chain
    4.2 Long-acting Injectable Medications Upstream Analysis
    4.3 Long-acting Injectable Medications Midstream Analysis
    4.4 Long-acting Injectable Medications Downstream Analysis
5 Sights by Type
    5.1 Long-acting Injectable Medications Classification by Type
        5.1.1 Second Generation
        5.1.2 First Generation
    5.2 by Type, Global Long-acting Injectable Medications Market Size & CAGR, 2020 VS 2024 VS 2031
    5.3 by Type, Global Long-acting Injectable Medications Market Size, 2020-2031
6 Sights by Product
    6.1 Long-acting Injectable Medications Classification by Product
        6.1.1 Fluphenazine
        6.1.2 Haloperido
        6.1.3 Decanoate
        6.1.4 Risperidone
        6.1.5 Others
    6.2 by Product, Global Long-acting Injectable Medications Market Size & CAGR, 2020 VS 2024 VS 2031
    6.3 by Product, Global Long-acting Injectable Medications Market Size, 2020-2031
7 Sights by Marketing Channel
    7.1 Long-acting Injectable Medications Classification by Marketing Channel
        7.1.1 Hospital
        7.1.2 Clinic
        7.1.3 Online
    7.2 by Marketing Channel, Global Long-acting Injectable Medications Market Size & CAGR, 2020 VS 2024 VS 2031
    7.3 by Marketing Channel, Global Long-acting Injectable Medications Market Size, 2020-2031
8 Sights by Application
    8.1 Long-acting Injectable Medications Segment by Application
        8.1.1 Schizophrenia
        8.1.2 Bipolar Disorder
        8.1.3 HIV
        8.1.4 Diabete
        8.1.5 Others
    8.2 by Application, Global Long-acting Injectable Medications Market Size & CAGR, 2020 VS 2024 VS 2031
    8.3 by Application, Global Long-acting Injectable Medications Market Size, 2020-2031
9 Sights by Region
    9.1 By Region, Global Long-acting Injectable Medications Market Size, 2020 VS 2024 VS 2031
    9.2 By Region, Global Long-acting Injectable Medications Market Size, 2020-2031
    9.3 North America
        9.3.1 North America Long-acting Injectable Medications Market Size & Forecasts, 2020-2031
        9.3.2 By Country, North America Long-acting Injectable Medications Market Size Market Share
    9.4 Europe
        9.4.1 Europe Long-acting Injectable Medications Market Size & Forecasts, 2020-2031
        9.4.2 By Country, Europe Long-acting Injectable Medications Market Size Market Share
    9.5 Asia Pacific
        9.5.1 Asia Pacific Long-acting Injectable Medications Market Size & Forecasts, 2020-2031
        9.5.2 By Country/Region, Asia Pacific Long-acting Injectable Medications Market Size Market Share
    9.6 South America
        9.6.1 South America Long-acting Injectable Medications Market Size & Forecasts, 2020-2031
        9.6.2 By Country, South America Long-acting Injectable Medications Market Size Market Share
    9.7 Middle East & Africa
10 Sights by Country Level
    10.1 By Country, Global Long-acting Injectable Medications Market Size & CAGR，2020 VS 2024 VS 2031
    10.2 By Country, Global Long-acting Injectable Medications Market Size, 2020-2031
    10.3 United States
        10.3.1 United States Long-acting Injectable Medications Market Size, 2020-2031
        10.3.2 By Company, United States Long-acting Injectable Medications Revenue Market Share, 2024
        10.3.3 by Type, United States Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
        10.3.4 by Application, United States Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
    10.4 Europe
        10.4.1 Europe Long-acting Injectable Medications Market Size, 2020-2031
        10.4.2 By Company, Europe Long-acting Injectable Medications Revenue Market Share, 2024
        10.4.3 by Type, Europe Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
        10.4.4 by Application, Europe Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
    10.5 China
        10.5.1 China Long-acting Injectable Medications Market Size, 2020-2031
        10.5.2 By Company, China Long-acting Injectable Medications Revenue Market Share, 2024
        10.5.3 by Type, China Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
        10.5.4 by Application, China Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
    10.6 Japan
        10.6.1 Japan Long-acting Injectable Medications Market Size, 2020-2031
        10.6.2 By Company, Japan Long-acting Injectable Medications Revenue Market Share, 2024
        10.6.3 by Type, Japan Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
        10.6.4 by Application, Japan Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
    10.7 South Korea
        10.7.1 South Korea Long-acting Injectable Medications Market Size, 2020-2031
        10.7.2 By Company, South Korea Long-acting Injectable Medications Revenue Market Share, 2024
        10.7.3 by Type, South Korea Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
        10.7.4 by Application, South Korea Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
    10.8 Southeast Asia
        10.8.1 Southeast Asia Long-acting Injectable Medications Market Size, 2020-2031
        10.8.2 By Company, Southeast Asia Long-acting Injectable Medications Revenue Market Share, 2024
        10.8.3 by Type, Southeast Asia Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
        10.8.4 by Application, Southeast Asia Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
    10.9 India
        10.9.1 India Long-acting Injectable Medications Market Size, 2020-2031
        10.9.2 By Company, India Long-acting Injectable Medications Revenue Market Share, 2024
        10.9.3 by Type, India Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
        10.9.4 by Application, India Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
    10.10 Middle East & Africa
        10.10.1 Middle East & Africa Long-acting Injectable Medications Market Size, 2020-2031
        10.10.2 By Company, Middle East & Africa Long-acting Injectable Medications Revenue Market Share, 2024
        10.10.3 by Type, Middle East & Africa Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
        10.10.4 by Application, Middle East & Africa Long-acting Injectable Medications Revenue Market Share, 2024 VS 2031
11 Company Profile
    11.1 Johnson & Johnson
        11.1.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
        11.1.2 Johnson & Johnson Company Profile and Main Business
        11.1.3 Johnson & Johnson Long-acting Injectable Medications Models, Specifications, and Application
        11.1.4 Johnson & Johnson Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.1.5 Johnson & Johnson Recent Developments
    11.2 Otsuka
        11.2.1 Otsuka Company Information, Head Office, Market Area, and Industry Position
        11.2.2 Otsuka Company Profile and Main Business
        11.2.3 Otsuka Long-acting Injectable Medications Models, Specifications, and Application
        11.2.4 Otsuka Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.2.5 Otsuka Recent Developments
    11.3 GSK
        11.3.1 GSK Company Information, Head Office, Market Area, and Industry Position
        11.3.2 GSK Company Profile and Main Business
        11.3.3 GSK Long-acting Injectable Medications Models, Specifications, and Application
        11.3.4 GSK Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.3.5 GSK Recent Developments
    11.4 Eli Lilly
        11.4.1 Eli Lilly Company Information, Head Office, Market Area, and Industry Position
        11.4.2 Eli Lilly Company Profile and Main Business
        11.4.3 Eli Lilly Long-acting Injectable Medications Models, Specifications, and Application
        11.4.4 Eli Lilly Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.4.5 Eli Lilly Recent Developments
    11.5 Alkermes
        11.5.1 Alkermes Company Information, Head Office, Market Area, and Industry Position
        11.5.2 Alkermes Company Profile and Main Business
        11.5.3 Alkermes Long-acting Injectable Medications Models, Specifications, and Application
        11.5.4 Alkermes Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.5.5 Alkermes Recent Developments
    11.6 Teva Pharmaceuticals
        11.6.1 Teva Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        11.6.2 Teva Pharmaceuticals Company Profile and Main Business
        11.6.3 Teva Pharmaceuticals Long-acting Injectable Medications Models, Specifications, and Application
        11.6.4 Teva Pharmaceuticals Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.6.5 Teva Pharmaceuticals Recent Developments
    11.7 Mapi Pharma
        11.7.1 Mapi Pharma Company Information, Head Office, Market Area, and Industry Position
        11.7.2 Mapi Pharma Company Profile and Main Business
        11.7.3 Mapi Pharma Long-acting Injectable Medications Models, Specifications, and Application
        11.7.4 Mapi Pharma Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.7.5 Mapi Pharma Recent Developments
    11.8 Lupin
        11.8.1 Lupin Company Information, Head Office, Market Area, and Industry Position
        11.8.2 Lupin Company Profile and Main Business
        11.8.3 Lupin Long-acting Injectable Medications Models, Specifications, and Application
        11.8.4 Lupin Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.8.5 Lupin Recent Developments
    11.9 Amneal
        11.9.1 Amneal Company Information, Head Office, Market Area, and Industry Position
        11.9.2 Amneal Company Profile and Main Business
        11.9.3 Amneal Long-acting Injectable Medications Models, Specifications, and Application
        11.9.4 Amneal Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.9.5 Amneal Recent Developments
    11.10 Neuraxpharm
        11.10.1 Neuraxpharm Company Information, Head Office, Market Area, and Industry Position
        11.10.2 Neuraxpharm Company Profile and Main Business
        11.10.3 Neuraxpharm Long-acting Injectable Medications Models, Specifications, and Application
        11.10.4 Neuraxpharm Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.10.5 Neuraxpharm Recent Developments
    11.11 Luye Pharma
        11.11.1 Luye Pharma Company Information, Head Office, Market Area, and Industry Position
        11.11.2 Luye Pharma Company Profile and Main Business
        11.11.3 Luye Pharma Long-acting Injectable Medications Models, Specifications, and Application
        11.11.4 Luye Pharma Long-acting Injectable Medications Revenue and Gross Margin, 2020-2025
        11.11.5 Luye Pharma Recent Developments
12 Conclusion
13 Appendix
    13.1 Research Methodology
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Market Estimation Model
    13.4 Disclaimer